Thursday, Apr 25 2024 | Time 20:32 Hrs(IST)
image
Business Economy


Vivimed receives export order for supply of 'Favulous' tablets 200 mg : Favipiravir

Mumbai, Aug 5 (UNI) Pharma major ,Vivimed Labs on Wednesday announced the manufacturing of "Favulous" tablets 200 mg (Favipiravir) against export order.
Favulous tablets 200 mg (Favipiravir) is used for the treatment of mild to moderate cases of Covid-19 .
Favipiravir is the only oral anti-viral treatment approved in various countries for the potential treatment of patients with mild to moderate Covid-19 disease. The initial Export order Value is worth over Rs 100 Million. we expect to receive further repeat orders during the Year.
Commenting on the launch, Ramesh Krishnamurthy, CEO of Vivimed Labs Ltd said, "With over 300,000 Covid-19 cases being reported daily thought out the world, there is an urgent need to provide more treatment options to healthcare professionals. We are launching "Favulous" at an economical price to make the drug accessible to more and more patients thereby ensuring good health and reducing their financial burden. This is in line with our continuous efforts to support world's pandemic response."
The company will work closely with the various governments and medical community to ensure availability of "Favulous" to patients across the world.
UNI JS NV JW2125
More News

Tech Mahindra net at Rs 661 crore in Q4; Company gives dividend of Rs 28 per share

25 Apr 2024 | 7:28 PM

New Delhi, April 25 (UNI) Mahindra Group company Tech Mahindra, a technology consulting and digital solutions provider, on Thursday reported about 41 per cent decline in net profit at Rs 661 crore year-on-year basis for the fourth quarter ended March 31, 2024.

see more..

Kottayam-Kochi Rubber Market Rates

25 Apr 2024 | 7:26 PM

Kottayam, April 25 (UNI) Following were the Rubber Market rates announced by the Rubber Board here today per quintal.

see more..
Indusind Bank net up 15 pc in Q4

Indusind Bank net up 15 pc in Q4

25 Apr 2024 | 7:10 PM

New Delhi, April 25 (UNI) Leading private bank Indusind on Thursday reported a 15 percent jump in net profit at Rs 2,349 crore in Q4 of FY 2023–24, compared to Rs 2,043 crore in the same quarter in 2022–23.

see more..

25 Apr 2024 | 6:53 PM

New Delhi, April 25 (UNI) Leading private bank Indusind on Thursday reported 15 percent jump in net profit at Rs 2,349 crore in Q4 of FY 2023-24 compared to Rs 2,043 crore in the same quarter in 2022-23.

see more..

Regulations to become more stringent, demanding in coming years : CUB MD

25 Apr 2024 | 6:40 PM

Chennai, Apr 25 (UNI) “Regulations are going to be here, and they are going to
get more stringent as there is a learning depending upon the changes in the
environment and the role of the CFO's,” City Union Bank (CUB) MD and CEO
Dr N Kamakodi observed on Thursday.

see more..
image